AWP
TMO icon

Accretive Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Accretive Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Buy
3,366
+13
+0.4% +$7.05K 0.47% 60
2025
Q4 		$1.94M Buy
3,353
+30
+0.9% +$17K 0.58% 54
2025
Q3 		$1.61M Buy
3,323
+75
+2% +$34.9K 0.49% 62
2025
Q2 		$1.32M Buy
3,248
+41
+1% +$17.1K 0.43% 73
2025
Q1 		$1.31M Buy
3,207
+331
+12% +$179K 0.46% 69
2024
Q4 		$1.5M Buy
2,876
+2,279
+382% +$1.25M 0.64% 54
2024
Q3 		$369K Sell
597
-29
-5% -$17.2K 0.15% 111
2024
Q2 		$346K Hold
626
– – 0.14% 114
2024
Q1 		$358K Sell
626
-14
-2% -$7.86K 0.16% 115
2023
Q4 		$340K Buy
640
+48
+8% +$23.2K 0.16% 113
2023
Q3 		$300K Hold
592
– – 0.18% 106
2023
Q2 		$309K Buy
592
+6
+1% +$3.24K 0.18% 101
2023
Q1 		$338K Buy
586
+3
+0.5% +$1.69K 0.22% 100
2022
Q4 		$321K Buy
583
+175
+43% +$92.7K 0.22% 99
2022
Q3 		$207K Hold
408
– – 0.16% 101
2022
Q2 		$222K Sell
408
-8
-2% -$4.4K 0.16% 103
2022
Q1 		$246K Hold
416
– – 0.15% 102
2021
Q4 		$278K Sell
416
-9
-2% -$5.62K 0.18% 99
2021
Q3 		$243K Buy
425
+26
+7% +$14.3K 0.17% 101
2021
Q2 		$201K Sell
399
-71
-15% -$33.5K 0.14% 107
2021
Q1 		$214K Sell
470
-30
-6% -$14.3K 0.19% 95
2020
Q4 		$233K Buy
+500
New +$234K 0.23% 92

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Accretive Wealth Partners's TMO Position: Q1 2026 in Review

Accretive Wealth Partners increased its Thermo Fisher Scientific (TMO) stake by 0.39% in Q1 2026, buying an estimated $7.05K and bringing the position to 3,366 shares worth $1.65M. The position accounts for 0.47% of the portfolio, ranked #60.

Accretive Wealth Partners first reported a position in TMO in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.94M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Accretive Wealth Partners held 3,366 shares of Thermo Fisher Scientific worth $1.65M as of Q1 2026.
  • Accretive Wealth Partners bought 13 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.05K.
  • Thermo Fisher Scientific made up 0.47% of Accretive Wealth Partners's portfolio in Q1 2026, its #60 holding.
  • Accretive Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 22 quarters since.
  • Accretive Wealth Partners's Thermo Fisher Scientific position peaked at $1.94M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Accretive Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.